Montage Laboratories Commences Construction of Manufacturing Unit 3 to Expand Production Footprint

Date:

Share post:

Montage Laboratories Pvt. Ltd., a manufacturer of pharmaceutical formulations, has performed the Bhoomi Pujan(groundbreaking ceremony) for its upcoming manufacturing facility, Unit 3. The milestone marks a new phase in the company’s infrastructure and capacity expansion roadmap.

​The new unit is designed to enhance Montage Laboratories’ manufacturing capabilities and strengthen its production capacity to meet the growing domestic and global demand for quality-driven formulations. The facility will operate under Current Good Manufacturing Practice (cGMP) standards, expanding on the company’s existing operations in Himmatnagar.

​Company leadership, stakeholders, and team members attended the groundbreaking ceremony. The management highlighted that this strategic investment is a vital step toward scaling up operations, enhancing technical infrastructure, and reinforcing the company’s long-standing commitment to delivering high-quality, affordable healthcare solutions.

​Construction and development work for Unit 3 will commence immediately, with further details on production lines and project timelines to be announced as development progresses.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

AIIA Rolls Out “Garbhini Mitra” Programme to Widen Community-Level Maternal Support Through Ayurveda

The All India Institute of Ayurveda (AIIA) in New Delhi, an autonomous body under the Ministry of Ayush, has...

GSK’s Hibsago Becomes World’s First Approved Functional Cure for Chronic Hepatitis B

GSK has secured its first global regulatory approval for Hibsago(bepirovirsen), marking the debut of a functional cure option for...

Fortis Healthcare Launches Lung Failure Clinics in New Delhi to Enhance Advanced Respiratory and Transplant Care

Fortis Healthcare has announced the launch of dedicated Lung Failure Clinics at its Shalimar Bagh and Vasant Kunj facilities in New Delhi....

Symbiotec Pharmalab Announces ₹1,757 Crore IPO to Fuel Biopharma Growth

Symbiotec Pharmalab, a leading research and development-driven pharmaceutical and biotechnology player, has announced details of its ₹1,757 crore Initial...